Impact we've achieved with our research:
A study by Cancer Council NSW has revealed that over 1 in 3 lung cancer patients seek emergency care around the time of diagnosis.
Using the latest approaches to genomic sequencing, Associate Professor Marcel Dinger and his team are working to identify genes that contribute to rare head and neck cancers.
This world-first trial of cervical screening in an HPV-vaccinated population, will further increase our knowledge of Australia's new cervical cancer screening program.
Cancer Council NSW researchers have evaluated the performance of a lung cancer risk tool used to predict current and ex-smokers at the highest risk of developing lung cancer.
Dr Jeremy Henson and his team have discovered a new way to test for aggressive cancers. The test could aid in early diagnosis and help with devising the best treatment for each patient.